oxybutynin has been researched along with Overweight in 2 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Overweight: A status with BODY WEIGHT that is above certain standards. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat (ADIPOSE TISSUE), hence overweight does not equal over fat.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Norman, C | 1 |
| Rollene, NL | 1 |
| Erickson, D | 1 |
| Miles, JM | 1 |
| Bowers, CY | 1 |
| Veldhuis, JD | 1 |
| Westhoff, CL | 1 |
| Reinecke, I | 1 |
| Bangerter, K | 1 |
| Merz, M | 1 |
2 trials available for oxybutynin and Overweight
| Article | Year |
|---|---|
Estradiol regulates GH-releasing peptide's interactions with GH-releasing hormone and somatostatin in postmenopausal women.
Topics: Aged; Arginine; Body Mass Index; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Feedb | 2014 |
Impact of body mass index on suppression of follicular development and ovulation using a transdermal patch containing 0.55-mg ethinyl estradiol/2.1-mg gestodene: a multicenter, open-label, uncontrolled study over three treatment cycles.
Topics: Adolescent; Adult; Body Mass Index; Contraceptive Agents, Female; Drug Combinations; Estradiol; Ethi | 2014 |